Novel Selective Cyp26 Antagonists for Dermatological Diseases

Cyp26 inhibitor compounds treat diseases such as psoriasis, while avoiding retinoid related side affects.

Published: 5th October 2018
Novel Selective Cyp26 Antagonists for Dermatological Diseases
Please note, header image is purely illustrative. Source: Bobjgalindo, Wikimedia, CC BY-SA 3.0
Patents
  • 1 US provisional patent application and another PCT application: both claiming novel but separate compositions of matter for inhibition of either Cyp26A1 or Cyp26B1
IP Status
  • Patent application submitted
  • Provisional patent
Seeking
  • University spin out
  • Development partner
  • Seeking investment